Appointment dossier — Endometrial Cancer
Bring this to your appointment. It summarizes what published studies report — it is not medical advice and does not say anything works. Decisions are yours and your care team’s.
Compounds studied in Endometrial Cancer
- Carboplatin — Review evidence · 0 positive / 1 negative-mixed · PMID 33183764
“Positive” means a study reported a positive result — most are early lab/animal work that may not translate to people.
Open recruiting trials (18)
- NCT06943521 · Phase 1 / Phase 2 — A Study of MT-4561 in Patients With Various Advanced Solid Tumors (United States)
- NCT07377734 · Phase 2 — Intrauterine Injection of Type III Collage in FST of EC/AEH (China)
- NCT06840886 · Phase 1 — A Study of PHST001 in Advanced Solid Tumors (United States)
- NCT05819892 · Phase 1 — Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer (United States)
- NCT06771219 · Phase 1 — SLV-154 Treatment of Metastatic Solid Tumors (United States)
- NCT07062016 — Molecular and ctDNA Characterization of High-Risk Endometrial Cancer (United States)
- NCT05051722 — Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer (United States)
- NCT06619002 — Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies (Italy)
- NCT06365905 — Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding (United States)
- NCT07194551 — Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire (Canada)
- NCT06284343 — The Gynecological Cancer Associated Thrombosis (GynCAT) Study (Italy)
- NCT07327489 — Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (United States)
- NCT05179447 — PROfiling Based Endometrial Cancer Adjuvant Therapy (China)
- NCT06800612 — Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers (Italy)
- NCT06339827 — ASk Questions in GYnecologic Oncology (ASQ-GYO) (United States)
- NCT06360653 — a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer (Italy)
- NCT07027046 — Application of da Vinci SP for Endometrial Cancer Surgical Staging (Italy)
- NCT04291612 — Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease (United States)
Most-relevant first: trials that name Endometrial Cancer, then broader trials you may still qualify for. 337 recruiting trials name this cancer on ClinicalTrials.gov. Eligibility is decided by each trial's team — bring these NCT numbers to your appointment.
Questions to ask your oncologist
- Of the open trials I found (for example NCT06943521), am I eligible for any — here or at a larger cancer center?
- What is my exact diagnosis — the type, subtype, stage, and grade?
- Has my tumor had molecular or genomic testing (e.g. next-generation sequencing), and what did it find?
- Should I have inherited (germline) genetic testing, and could it affect my treatment or my family?
- What is the goal of treatment for me — cure, long-term control, or comfort?
- What are all of my standard treatment options, and what does each one involve?
- What is the realistic benefit of each option, in actual numbers?
- What are the most common and the most serious side effects, and how are they managed?
- How will we know if treatment is working, and how often will I be scanned or tested?
- If the first treatment doesn't work, what are the next options?
- Are there gentler options if I want to prioritize quality of life?
- Am I eligible for any clinical trials — here or at a larger/academic cancer center?
- Is my case reviewed by a multidisciplinary tumor board?
- Would a second opinion at a center that treats my cancer often be worthwhile?
- Could any of my prescriptions, over-the-counter drugs, or supplements interfere with treatment?
- Which symptoms are emergencies, and who do I call after hours?
- Should I see palliative or supportive care alongside my treatment?
- How will treatment affect my daily life, work, and (if it matters to me) fertility?
- What can I safely do myself — diet and activity — and is anything I'm taking risky?
- What will treatment cost, and is financial assistance available?
- Should my tumor tissue be stored (biobanked) for future testing or trials?